| № |
Сompany |
Date transmission |
Сomments |
| 1. |
ТЕVA |
July 2017 |
There are no critical comments |
| 2. |
Sanofi |
June 2017 |
There are no critical comments |
| 3. |
Johnson & Johnson |
April 2017 |
There are no critical comments |
| 4. |
Astellas Pharma |
March 2017 |
There are no critical comments |
| 5. |
ТЕVA |
Dесember 2016 |
There are no critical comments |
| 6. |
NOVARTIS Pharma AG |
September 2016 |
There are no critical comments |
| 7. |
Abbot Products Operations AG |
June 2016 |
There are no critical comments |
| 8. |
Alcon |
June 2016 |
There are no critical comments |
| 9. |
Laboratoires Thea |
March 2016 |
There are no critical comments |
| 10. |
Roche |
February 2016 |
There are no critical comments |
| 11. |
Sanofi |
July 2015 |
There are no critical comments |
| 12. |
AstraZeneca |
May 2015 |
There are no critical comments |
| 13. |
Pfizer |
February 2015 |
There are no critical comments |
| 14. |
TUV Rheinland Ukraine |
October 2014 |
There are no critical comments |
| 15. |
Johnson & Johnson |
October 2013 |
There are no critical comments |
| 16. |
BAYER |
September 2012 |
There are no critical comments |
| 17. |
Abbot Products Operations AG |
November 2012 |
There are no critical comments |
| 18. |
Johnson & Johnson |
August 2012 |
There are no critical comments |
| 19. |
NOVARTIS Pharma AG |
November 2011 |
There are no critical comments |
| 20. |
NOVARTIS Consumer Health |
August 2011 |
There are no critical comments |
| 21. |
MEDA Pharmaceuticals Switzerland GmbH |
August 2011 |
There are no critical comments |
| 22. |
Pfizer |
July 2011 |
There are no critical comments |
| 23. |
ФАРМАСОФТ |
July 2011 |
There are no critical comments |
| 24. |
Johnson & Johnson |
June 2011 |
There are no critical comments |
| 25. |
ТЕVA |
June 2011 |
There are no critical comments |
| 26. |
UCB PHARMA GmbH в Украине |
May 2011 |
There are no critical comments |
| 27. |
MERCK SHARP & DOHME IDEA INC. |
April 2011 |
There are no critical comments |
| 28. |
ENERTAD RESOURCES Ltd |
March 2011 |
There are no critical comments |
| 29. |
Baxter |
February 2011 |
There are no critical comments |
| 30. |
AstraZeneca |
November 2010 |
There are no critical comments |
| 31. |
Roche |
September 2010 |
There are no critical comments |
| 32. |
NOVARTIS Pharma AG |
February 2009 |
There are no critical comments |
| 33. |
NOVARTIS Consumer Health |
February 2009 |
There are no critical comments |
